-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QClcLmz9EgCU3CHjWgct87g/WJKOb++iSk/+ekXmH/3kwQgtybgCpawviMaPZmAy 1iUzOQMVwCsjAGeTBBWjvA== 0001010412-05-000394.txt : 20051103 0001010412-05-000394.hdr.sgml : 20051103 20051102173800 ACCESSION NUMBER: 0001010412-05-000394 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20051103 DATE AS OF CHANGE: 20051102 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PharmaFrontiers Corp. CENTRAL INDEX KEY: 0001069308 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 760333165 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-81104 FILM NUMBER: 051174335 BUSINESS ADDRESS: STREET 1: 2635 CRESCENT RIDGE DRIVE CITY: THE WOODLANDS STATE: TX ZIP: 77381 BUSINESS PHONE: (281)272-9331 MAIL ADDRESS: STREET 1: 2635 CRESCENT RIDGE DRIVE CITY: THE WOODLANDS STATE: TX ZIP: 77381 FORMER COMPANY: FORMER CONFORMED NAME: PHARMAFRONTIERS CORP DATE OF NAME CHANGE: 20040816 FORMER COMPANY: FORMER CONFORMED NAME: SPORTAN UNITED INDUSTRIES INC DATE OF NAME CHANGE: 19990305 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: JARKESY GEORGE CENTRAL INDEX KEY: 0001282282 FILING VALUES: FORM TYPE: SC 13D MAIL ADDRESS: STREET 1: 18207 BURKHARDT CITY: TOMBALL STATE: TX ZIP: 77375 SC 13D 1 jarkesy13d.txt SCHEDULE 13D FOR GEORGE JARKESY UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 PharmaFrontiers, Corp. (Name of Issuer) COMMON STOCK, PAR VALUE $.05 PER SHARE. (Title of Class of Securities) 7171EN 10 6 (CUSIP Number) George Jarkesy 18207 Burkhardt Tomball, TX 77375 (832) 452-8820 -------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) June 4, 2004 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box [_]. NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). SCHEDULE 13D CUSIP NO. 7171EN 10 6 - ------------------------------------------------------------------------------ 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON George Jarkesy and the Jarkesy Foundation, Inc. - ------------------------------------------------------------------------------ 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) X (b) - ------------------------------------------------------------------------------ 3. SEC USE ONLY - ------------------------------------------------------------------------------ 4. SOURCE OF FUNDS PF - ------------------------------------------------------------------------------ 5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) - ------------------------------------------------------------------------------ 6. CITIZENSHIP OR PLACE OF ORGANIZATION USA & Texas - ------------------------------------------------------------------------------ 7. SOLE VOTING POWER 1,300,500 NUMBER OF SHARES 8. SHARED VOTING POWER BENEFICIALLY OWNED BY 395,755 EACH REPORTING PERSON 9. SOLE DISPOSITIVE POWER WITH 1,300,500 - ------------------------------------------------------------------------------ 10. SHARED DISPOSITIVE POWER 395,755 - ------------------------------------------------------------------------------ 11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,696,255 - ------------------------------------------------------------------------------ 12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES - ------------------------------------------------------------------------------ 13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 8.23% - ------------------------------------------------------------------------------ 14. TYPE OF REPORTING PERSON IN & CO - ------------------------------------------------------------------------------ SCHEDULE 13D ITEM 1. SECURITY AND ISSUER. This statement relates to the common stock, par value $.05 per share (the "Common Stock"), of PharmaFrontiers, Corp, a Texas corporation (the "Company" or the "Issuer"). The Company's principal executive offices are located at 2635 Cresent Ridge Drive, The Woodlands, TX 77381. ITEM 2. IDENTITY AND BACKGROUND. (a) This Schedule is being filed by George Jarkesy. (b) The mailing address of Mr. Jarkesy is 18207 Burkhardt, Tomball, Texas 77375. (c) Mr. Jarkesy is a stockholder of the Company. (d) During the last five years, Mr. Jarkesy has not been convicted in any criminal proceeding (excluding traffic violations and similar misdemeanors). (e) During the last five years, Mr. Jarkesy was not a party to a civil proceeding of a judicial or administrative body of competent jurisdiction which, as a result of such proceeding, made him subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect thereto. (f) Mr. Jarkesy is a citizen of the United States of America. ITEM 2. IDENTITY AND BACKGROUND. (a) This Schedule is being filed by the Jarkesy Foundation, Inc. (b) The mailing address of the Jarkesy Foundation, Inc. is 18207 Burkhardt, Tomball, Texas 77375. (c) The Jarkesy Foundation, Inc. is a stockholder in the Company. (d) During the last five years, Mr. Jarkesy has not been convicted in any criminal proceeding (excluding traffic violations and similar misdemeanors). (e) During the last five years, Mr. Jarkesy was not a party to a civil proceeding of a judicial or administrative body of competent jurisdiction which, as a result of such proceeding, made him subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect thereto. (f) The Jarkesy Foundation, Inc. is organized in the state of Texas. ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION. Personal Funds ITEM 4. PURPOSE OF TRANSACTION. ITEM 5. INTEREST IN SECURITIES OF THE ISSUER. (a) According to the Company, there were 20,609,545 shares of Common Stock outstanding as of November 2, 2005. Mr. Jarkesy is the direct owner of 1,300,500 shares and an indirect owner of 395,755 shares of Common Stock, which represents approximately 8.23% of the outstanding shares of the Company's Common Stock. (b) Mr. Jarkesy has the sole power to direct the vote of 1,300,500 shares and the shared power to direct the vote of 395,755 shares of Common Stock owned by him and the sole power to direct the disposition of 1,300,500 shares and the shared power to direct the disposition of 395,755 shares. (c) Except as set forth in this Schedule 13D, there have been no sales or purchases with respect to the Company's shares effected during the past sixty days by Mr. Jarkesy. (d) Not Applicable. (e) Not Applicable. ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER. Except as described above and elsewhere in this Schedule 13D, there are no contracts, arrangements, understandings or relationships (legal or otherwise) among Mr. Jarkesy and any other person with respect to any securities of the Company. ITEM 7. MATERIAL TO BE FILED AS EXHIBITS. None; not applicable. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: 11/2/05 /s/ George R. Jarkesy, Jr. - -------------------------- George R. Jarkesy, Jr. -----END PRIVACY-ENHANCED MESSAGE-----